New CoreValve Evolut 23 mm technology for treatment of degenerated bioprosthesis.
Heart Lung Circ
; 23(2): 183-5, 2014 Feb.
Article
em En
| MEDLINE
| ID: mdl-24021234
ABSTRACT
The treatment of degenerated surgical bio-prosthetic heart valves (BHV) has been reported as a novel indication for TAVI. The intervention may be complicated by high residual transvalvular gradients and coronary ostia obstruction, especially in small size BHV. We report two cases of BHVs treated with the new CoreValve Evolut 23 mm highlighting the importance of fluoroscopic guidance, based on BHV markers, in achieving a correct TAVI implantation. The small dimensions of the new CoreValve Evolut 23 allowed us to obtain low residual gradients even in this particular subset of degenerated BHV.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Bioprótese
/
Próteses Valvulares Cardíacas
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Revista:
Heart Lung Circ
Assunto da revista:
ANGIOLOGIA
/
CARDIOLOGIA
Ano de publicação:
2014
Tipo de documento:
Article